New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
07:36 EDTBCR, MDTMedtronic balloon likely to be superior to C.R. Bard product, says Wells Fargo
After examining data disclosed by C.R. Bard (BCR) on its drug-coated balloon, Wells Fargo thinks the efficacy of Medtronic's drug-coated balloon will be superior. The firm keeps an Outperform rating on Medtronic.
News For MDT;BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
16:33 EDTMDTMedtronic reports 5.1% passive stake in Intersect ENT
Subscribe for More Information
15:46 EDTMDTPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
08:36 EDTMDTMedtronic receives FDA approval for for the Medtronic Enterra II System
Subscribe for More Information
January 21, 2015
18:06 EDTMDTS&P announces changes to the S&P 500, MidCap 400, SmallCap 600 indices
Subscribe for More Information
January 20, 2015
06:32 EDTBCRC.R. Bard upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded C.R. Bard to Neutral on expectations drug-coated balloons growth in the U.S. is likely to exceed consensus expectations. The firm raised its price target for shares to $178 from $162.
January 13, 2015
17:13 EDTBCRC.R. Bard wins favorable patent ruling over W.L. Gore & Associates
Subscribe for More Information
January 12, 2015
13:02 EDTMDTMedtronic sees Coviden deal closing in last week of January, early February
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use